SuperworthQ32 Bio shares outstanding QTTB
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 20.3M
- On a year earlier
- +66.8%
- more shares
Q32 Bio had 20.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 66.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2023 | 354.3K | −89% |
| FY2022 | 3.2M | +1% |
| FY2021 | 3.2M | +19% |
| FY2020 | 2.7M | +9% |
| FY2019 | 2.4M | +20% |
| FY2018 | 2M | +1300% |
| FY2017 | 145.1K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 20.3M | +67% | |
| Q1 FY26 | 14.1M | +16% | |
| Q3 FY25 | 12.2M | +1% | |
| Q2 FY25 | 12.2M | +2% | |
| Q1 FY25 | 12.2M | +423% | |
| Q3 FY24 | 12.1M | +3387% | |
| Q2 FY24 | 12M | +3339% | |
| Q1 FY24 | 2.3M | +577% | |
| Q4 FY23 | 354.3K | −89% | |
| Q3 FY23 | 346.3K | −89% | |
| Q2 FY23 | 347.9K | −89% | |
| Q1 FY23 | 344.6K | −89% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Q32 Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.